9th Annual Needham Healthcare Conference
June 09 - June 10, 2010
Needham & Company’s 9th Annual Healthcare Conference is a high-impact forum for institutional investors and venture capital firms to hear the latest updates from senior management teams of both public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology and Diagnostics sectors. Over the course of two days, attendees can participate in moderated company presentations, as well as expert panels of clinical and industry professionals. One-on-one meetings with companies will be available for qualified institutional investors and venture capital firms. Please contact your Needham salesperson for registration details as space will be limited.
http://www.needhamco.com/Default/InstitutionalSalesAndTrading/Conferences.aspx
June 09 - June 10, 2010
Needham & Company’s 9th Annual Healthcare Conference is a high-impact forum for institutional investors and venture capital firms to hear the latest updates from senior management teams of both public and private companies in the Biotechnology, Specialty Pharmaceuticals, Medical Technology and Diagnostics sectors. Over the course of two days, attendees can participate in moderated company presentations, as well as expert panels of clinical and industry professionals. One-on-one meetings with companies will be available for qualified institutional investors and venture capital firms. Please contact your Needham salesperson for registration details as space will be limited.
http://www.needhamco.com/Default/InstitutionalSalesAndTrading/Conferences.aspx
Longterm Investment, Biotechs & High Yield Dividend Stocks ... #board-11828



Recent ASM News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2026 09:16:33 PM
- Avino Delivers Record Q1 2026 Financial Results • ACCESS Newswire • 05/13/2026 09:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2026 09:05:45 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/12/2026 08:15:15 PM
- Bonanza Silver Returns: 9,510 g/t Drill Hit Reframes a Cobalt-Gowganda Discovery as the Sixth Consecutive Deficit Year Tightens • PR Newswire (Canada) • 05/04/2026 02:00:00 PM
- Bonanza Silver Returns: 9,510 g/t Drill Hit Reframes a Cobalt-Gowganda Discovery as the Sixth Consecutive Deficit Year Tightens • PR Newswire (US) • 05/04/2026 02:00:00 PM
- Avino Announces Q1 2026 Production Results • ACCESS Newswire • 04/23/2026 02:20:00 PM
- Avino Announces Q1 2026 Production Results • ACCESS Newswire • 04/23/2026 11:15:00 AM
- Avino Announces Inaugural Consolidated Mineral Reserves • ACCESS Newswire • 04/16/2026 11:15:00 AM
- Avino Announces Normal Course Issuer Bid for Common Shares • ACCESS Newswire • 04/06/2026 11:15:00 AM
- Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)] • Edgar (US Regulatory) • 03/27/2026 08:16:30 PM
- Avino Reports Exceptional 2025 Results and Advances Multi-Asset Growth Strategy; Significant Improvements Across Key Financial Metrics; Treasury Reaches Record Levels • ACCESS Newswire • 03/10/2026 09:15:00 PM
- Video - CEO Clips: Avino Silver & Gold Mines Targets Growth to Three Producing Assets • Newsfile • 02/27/2026 08:00:00 PM
- Avino Provides 2026 Outlook and Highlights Key 2025 Milestones • ACCESS Newswire • 02/19/2026 12:15:00 PM
- Avino Announces Filing of Final Base Shelf Prospectus • ACCESS Newswire • 02/13/2026 12:15:00 PM
- Avino Appoints Linda Broughton to The Board of Directors • ACCESS Newswire • 02/05/2026 12:15:00 PM
